Clinical Trial Update: Coproporphyrine Isomers and Methotrexate Elimination

View source ↗

Summary

This completed clinical trial update investigates coproporphyrin isomer profiles and methotrexate elimination in patients with Central Nervous System Neoplasms …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burkitt Lymphoma
• Central Nervous System Neoplasms
• Diffuse Large B-cell Lymphoma
• Precursor B-cell Lymphoblastic Leukemia Lymphoma

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Central Nervous System Neoplasms, Lymphoma, Large B-Cell, Diffuse | Status: COMPLETED